These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32505222)

  • 1. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
    von Weyhern CH; Kaufmann I; Neff F; Kremer M
    Lancet; 2020 Jun; 395(10241):e109. PubMed ID: 32505222
    [No Abstract]   [Full Text] [Related]  

  • 2. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
    Giusti B; Gori AM; Alessi M; Rogolino A; Lotti E; Poli D; Sticchi E; Bartoloni A; Morettini A; Nozzoli C; Peris A; Pieralli F; Poggesi L; Marchionni N; Marcucci R
    Thromb Haemost; 2020 Aug; 120(8):1233-1236. PubMed ID: 32455440
    [No Abstract]   [Full Text] [Related]  

  • 3. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.
    Canonico ME; Siciliano R; Scudiero F; Sanna GD; Parodi G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):262-264. PubMed ID: 32383737
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulation in COVID-19.
    Atallah B; Mallah SI; AlMahmeed W
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):260-261. PubMed ID: 32352517
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.
    Lopes RD; Fanaroff AC
    J Am Coll Cardiol; 2020 Oct; 76(16):1827-1829. PubMed ID: 33059827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.
    Turi S; Nardelli P; Landoni G
    Ann Card Anaesth; 2020; 23(3):258-259. PubMed ID: 32687078
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospital-based use of thromboprophylaxis in patients with COVID-19.
    Spyropoulos AC; Ageno W; Barnathan ES
    Lancet; 2020 May; 395(10234):e75. PubMed ID: 32330428
    [No Abstract]   [Full Text] [Related]  

  • 8. Arterial thrombosis and coronavirus disease 2019 in a patient with cancer.
    Nassabein R; Routy B; Blais N; Ayoub JP; Tehfé M
    Eur J Cancer; 2020 Jul; 134():1-2. PubMed ID: 32454394
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept.
    Gris JC; Perez-Martin A; Quéré I; Sotto A
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):381-382. PubMed ID: 32418867
    [No Abstract]   [Full Text] [Related]  

  • 10. How does COVID-19 affect the brain?
    Aamodt AH; Flinstad Harbo H; Eldøen G; Barratt-Due A; Aukrust P
    Tidsskr Nor Laegeforen; 2020 Jun; 140(10):. PubMed ID: 32602331
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation in COVID-19: DDI Perspective.
    Khiali S; Entezari-Maleki T
    Clin Appl Thromb Hemost; 2020; 26():1076029620959457. PubMed ID: 32936672
    [No Abstract]   [Full Text] [Related]  

  • 12. How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?
    Bertoletti L; Huisman MV
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32907888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care.
    Thomas W; White D; Cox-Morton S; MacDonald S; Besser M
    Thromb Res; 2020 Nov; 195():226-227. PubMed ID: 32795720
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and vitamin D deficiency, a fatal combination?
    van der Meulen J
    Neth J Med; 2020 Jul; 78(4):218. PubMed ID: 32641560
    [No Abstract]   [Full Text] [Related]  

  • 15. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
    Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
    Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lung lesions in severe COVID-19 : anatomoclinical confrontation].
    Delvenne M; de Froidmont S; Davenne E; Detrembleur N; Oury C; Delvenne P
    Rev Med Liege; 2020 Sup; 75(S1):101-108. PubMed ID: 33211430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke as a delayed manifestation of multi-organ thromboembolic disease in COVID-19 infection.
    Liu JL; Khawaja AM; Majjhoo AQ
    J Neurol Sci; 2020 Oct; 417():117071. PubMed ID: 32763511
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.
    Rokadiya S; Gil E; Stubbs C; Bell D; Herbert R
    J Infect; 2020 Sep; 81(3):e18-e19. PubMed ID: 32652166
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?
    Buioni D; Nardi P; Ruvolo G
    Clin Chim Acta; 2020 Sep; 508():109. PubMed ID: 32417209
    [No Abstract]   [Full Text] [Related]  

  • 20. Does active smoking worsen Covid-19?
    Carmona-Bayonas A; Jimenez-Fonseca P; Sánchez Arraez Á; Álvarez Manceñido F; Castañón E
    Eur J Intern Med; 2020 Jul; 77():129-131. PubMed ID: 32507518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.